NYTIMES (Nina Agrawal) - Early Research Suggests a Path to Predict and Prevent Lung Cancer
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing.
JUSTTHENEWS (Greg Piper) - RFK Jr. unveils 'sweeping' Lyme disease research, containment, treatment plan
Effort includes funding clinical research on products that may be able to stop Alpha-gal syndrome, which can create serious allergic reactions to red meat after tick bites.
NYTIMES (Ellen Barry) - Children’s Mental Health Visits Have Shot Up, Research Shows
Doctor’s visits for children’s anxiety rose by more than 250 percent over 10 years, according to a study of nearly two million children.
YOUTUBE (The Hill) - Watch Now! Reimagining Clinical Trials: Expanding Access by Meeting Patients Where They Are
Clinical trials are one of healthcare's most powerful tools, and one of its most underutilized pathways to patient care and innovative therapies. Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment, and making the path to new treatment options longer. Identifying and matching patients to the right clinical trial opportunity remains the single-largest cause of clinical trial delays, with many trials failing to meet their initial enrollment targets. But meeting an enrollment target doesn't guarantee the right patients are represented, as trials consistently fall short of reflecting the communities that carry the greatest burden of disease. What are the biggest…